W
WeMed
WeMed is an interventional diagnosis and treatment solutions provider
About WeMed
We-Med is a Beijing-based medical equipment company that operates in the healthcare technology market. The company's primary focus is on the development and distribution of advanced medical devices. These devices are designed to meet the needs of healthcare providers, including hospitals, clinics, and private practices, by improving the quality and efficiency of patient care.
We-Med's business model is centered around the sale of its medical devices. The company generates revenue through direct sales to healthcare providers, as well as through partnerships with other businesses in the healthcare industry. This model allows We-Med to maintain a steady stream of income while also investing in the research and development of new technologies.
The company's location in the Beijing Economic-Technological Development Area provides it with access to a thriving tech industry and a large pool of potential clients. This strategic positioning, combined with We-Med's commitment to innovation, positions the company well for future growth in the rapidly evolving healthcare technology market.
In summary, We-Med is a promising startup in the healthcare technology sector, with a strong focus on the development and distribution of advanced medical devices. The company's business model, which combines direct sales with strategic partnerships, provides a solid foundation for revenue generation and future growth.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Apr 2021 | $46M | $184M | Luxin Venture Capital · Haoyue Capital · Lake Bleu Capital · Suzhou Longmen Ventures | — |
| SERIES COther financing | Sep 2020 | $15M | $58M | Hillhouse Capital | — |
Growth signals
Latest recorded traffic for WeMed is 610 monthly website visits, up 1425% over the last three months. WeMed's team grew 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
- LCLuxin Venture Capital
- ECEfung Capital
Hillhouse Capital
Lake Bleu Capital- HCHaoyue Capital
- SVSuzhou Longmen Ventures
Other known investors1 additional known investor
NLVC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about WeMed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See WeMed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







